POSTED BY CARA SCHILLINGER ON 6/29/2012
FOR IMMEDIATE RELEASE
PULMONARY FIBROSIS FOUNDATION ANNOUNCES CO-FOUNDER LOSES FIGHT AGAINST IDIOPATHIC PULMONARY FIBROSIS
Foundation Gives Its Condolences and Heartfelt Gratitude to the Family of Dr. I.M. Rosenzweig and Will Name Research Award in His Honor
POSTED BY STEPHANIE SEWERYN ON 6/1/2012
By Anna Edney - May 30, 2012 11:00 PM CT
The $6.4 billion accord that Teva Pharmaceutical Industries Inc. (TEVA), Johnson & Johnson (JNJ) and other companies reached with U.S. regulators to fund new medicine and device reviews through 2017 passed the House of Representatives.